Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: RETRACTED ARTICLE: LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b

Fig. 1

Low TUBA4B is identified in GC and its downregulation predicts poor outcome. a qRT-PCR analysis of TUBA4B expression in 83 pairs of GC and adjacent normal tissues. b qRT-PCR analysis of TUBA4B expression in the human gastric epithelial GES-1 cells and five GC cell lines. c qRT-PCR analysis of TUBA4B expression in plasma samples from GC patients (n = 37) and healthy controls (n = 37). d The ROC curve for evaluating the prognostic value of plasma TUBA4B expression in GC. e, f The Kaplan–Meier survival curve of GC patients with low and high TUBA4B expression in our study or in TCGA database. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us